Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,553 | -38,168 | -21,397 | -88,602 | -61,503 |
| Depreciation Amortization | 1,918 | 1,206 | 615 | 2,455 | 1,784 |
| Accounts receivable | 2,387 | 1,160 | 455 | -1,138 | -2,070 |
| Accounts payable and accrued liabilities | -1,763 | -721 | 2,759 | -1,711 | -347 |
| Other Working Capital | 123 | -8,629 | 874 | 5,948 | 898 |
| Other Operating Activity | 10,115 | 6,934 | -2,307 | 10,461 | -2,170 |
| Operating Cash Flow | $-46,773 | $-38,218 | $-19,001 | $-72,587 | $-63,408 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -634 | -654 | -361 | -306 | -186 |
| Investing Cash Flow | $-634 | $-654 | $-361 | $-306 | $-186 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 25,000 | 25,000 | 25,000 | 110,000 | 110,000 |
| Common Stock Issued | 100,295 | 187 | N/A | 78,088 | 75,000 |
| Other Financing Activity | -25,111 | 0 | 187 | -110,172 | -108,345 |
| Financing Cash Flow | $100,184 | $25,187 | $25,187 | $77,916 | $76,655 |
| Exchange Rate Effect | -2,597 | -771 | -166 | 351 | 770 |
| Beginning Cash Position | 71,791 | 71,791 | 71,791 | 66,417 | 66,417 |
| End Cash Position | 121,971 | 57,335 | 77,450 | 71,791 | 80,248 |
| Net Cash Flow | $50,180 | $-14,456 | $5,659 | $5,374 | $13,831 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,773 | -38,218 | -19,001 | -72,587 | -63,408 |
| Capital Expenditure | -634 | -654 | -361 | -306 | -186 |
| Free Cash Flow | -47,407 | -38,872 | -19,362 | -72,893 | -63,594 |